Tharimmune Inc (THAR)
0.3651
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3651
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Cash from Financing (Quarterly): 0.3171M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.3171M |
| December 31, 2023 | 9.662M |
| September 30, 2023 | -0.306M |
| June 30, 2023 | 1.846M |
| March 31, 2023 | 0.5234M |
| December 31, 2022 | -0.1935M |
| September 30, 2022 | -0.3386M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.2496M |
| March 31, 2022 | 13.85M |
| December 31, 2021 | -0.0331M |
| September 30, 2021 | 0.3326M |
| June 30, 2021 | 0.2762M |
| March 31, 2021 | 0.323M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3386M
Minimum
Sep 2022
13.85M
Maximum
Mar 2022
2.000M
Average
0.3171M
Median
Mar 2024
Cash from Financing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -15.56M |
| Mirum Pharmaceuticals Inc | 1.205M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.825M |
| Free Cash Flow | -6.661M |
| Free Cash Flow Per Share (Quarterly) | -0.2403 |
| Free Cash Flow Yield | -297.7% |